Keeping health on track
ALAMEDA, Calif. — Abbott’s latest glucose meter, the FreeStyle Insulinx, is helping to bring blood-glucose monitoring up to speed with the latest in smartphone and tablet technology. The new meter features a touchscreen interface, automated logbook and is equipped with built-in FreeStyle Auto-Assist software that enables patients to track progress, analyze trends and easily display data for their healthcare providers.
Intimacy positioned more as health care
RH Labs just launched a line of intimacy health products endorsed by Laura Berman, a well-known sex and relationship expert who hosts the show “In The Bedroom” on the Oprah Winfrey Network. Berman collaborated on the design of every product in her line, the company noted.
It’s the kind of endorsement that will heighten the importance of intimacy health as part of an overall healthcare regimen.
Sales of intimacy enhancement devices were up 24.3% to $4.1 million over the 12 weeks ended Sept. 9, according to SymphonyIRI group data.
The article above is part of the DSN Category Review Series. For the complete Sexual Wellness Sell-Through Report, including extensive charts, data and more analysis, click here.
Diabetes management earns front-end spot
As more Americans join the ranks of diabetics, the opportunity to target these consumers at the shelf becomes more crucial.
Retailers like Rite Aid are using pull-box displays that allow customers to physically handle a blood-glucose meter before they make that purchase decision. That kind of consumer engagement, evident throughout Rite Aid’s latest Wellness format store, for example, helps anchor diabetes as a front-end destination center.
Sales of glucose meters were down 6.1% to $182.3 million for the 52 weeks ended Sept. 9 across food, drug and mass (excluding Walmart), according to SymphonyIRI Group data. But with the continued rise of diabetes diagnoses, there is opportunity beyond meters and lancets.
“There’s actually a place in the category for smoking cessation,” Dave Wendland, VP Hamacher Resource Group, noted. “I know that sounds odd, but there’s a link between those conditions [diabetes and smoking],” he said. “If you place products in a destination that meets more of their needs, they will buy more,” he said. That factor lends itself to dual placement opportunities and strategically-placed shelf talkers.
The article above is part of the DSN Category Review Series. For the complete Diabetes Buy-In Report, including extensive charts, data and more analysis, click here.